Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo
暂无分享,去创建一个
Katherine Luzuriaga | Donna Hochberg | John L Sullivan | Jaap M Middeldorp | D. Thorley-Lawson | D. Hochberg | M. Catalina | J. Sullivan | K. Luzuriaga | David A Thorley-Lawson | Michelle Catalina | Donna Hochberg
[1] J. Yates,et al. Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells , 1985, Nature.
[2] K. Rajewsky,et al. Maintenance of B-cell memory by long-lived cells generated from proliferating precursors , 1990, Nature.
[3] J. Pagano,et al. Expression of EBNA-1 mRNA Is Regulated by Cell Cycle during Epstein-Barr Virus Type I Latency , 1999, Journal of Virology.
[4] D. Thorley-Lawson,et al. Epstein-Barr virus and the B cell: that's all it takes. , 1996, Trends in microbiology.
[5] J. Robinson,et al. Plasmacytic differentiation of circulating Epstein-Barr virus-infected B lymphocytes during acute infectious mononucleosis , 1981, The Journal of experimental medicine.
[6] G. Winberg,et al. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1 , 1995, Journal of virology.
[7] D. Thorley-Lawson,et al. Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[8] D. Rowe,et al. Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes , 1992, Journal of virology.
[9] D. Thorley-Lawson,et al. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. , 2000, Immunity.
[10] K. Rajewsky,et al. Burkitt’s Lymphoma Is a Malignancy of Mature B Cells Expressing Somatically Mutated V Region Genes , 1995, Molecular medicine.
[11] M. Lipinski,et al. Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype. , 1987, Journal of immunology.
[12] M. Rowe,et al. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. , 1990, The Journal of general virology.
[13] Bin Yang,et al. Identification of the Site of Epstein-Barr Virus Persistence In Vivo as a Resting B Cell , 1998, Journal of Virology.
[14] J. Strominger,et al. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[15] M. Epstein,et al. Epstein-Barr (EB) virus genome-containing, EB nuclear antigen-negative B-lymphocyte populations in blood in acute infectious mononucleosis. , 1978, The Journal of general virology.
[16] D. Thorley-Lawson,et al. A model for persistent infection with Epstein-Barr virus: the stealth virus of human B cells. , 1999, Life sciences.
[17] K. Rajewsky,et al. Lack of deleterious somatic mutations in the CD95 gene of plasmablasts from systemic lupus erythematosus patients and autoantibody‐producing cell lines , 2002, European journal of immunology.
[18] J. Niederman,et al. Mitotic EBNA-positive lymphocytes in peripheral blood during infectious mononucleosis , 1980, Nature.
[19] J. Strominger,et al. A simple reverse transcriptase PCR assay to distinguish EBNA1 gene transcripts associated with type I and II latency from those arising during induction of the viral lytic cycle , 1996, Journal of virology.
[20] G. Klein. Epstein-Barr virus strategy in normal and neoplastic B cells , 1994, Cell.
[21] L. Young,et al. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state , 1994, Journal of virology.
[22] D. Thorley-Lawson,et al. EBV persistence in memory B cells in vivo. , 1998, Immunity.
[23] J. Arrand,et al. Characterization of the major Epstein-Barr virus-specific RNA in Burkitt lymphoma-derived cells , 1982, Journal of virology.
[24] D. Thorley-Lawson,et al. EBV Persistence Involves Strict Selection of Latently Infected B Cells1 , 2000, The Journal of Immunology.
[25] D. Thorley-Lawson,et al. Epstein-Barr virus: exploiting the immune system , 2001, Nature Reviews Immunology.
[26] D. Thorley-Lawson,et al. A novel form of Epstein-Barr virus latency in normal B cells in vivo , 1995, Cell.
[27] I. Ernberg,et al. Epstein-Barr virus: adaptation to a life within the immune system. , 1994, Trends in microbiology.
[28] R. Freeman,et al. The dispersal of mucosal memory B cells: evidence from persistent EBV infection. , 2002, Immunity.
[29] R. Freeman,et al. Epstein-Barr Virus–Infected Resting Memory B Cells, Not Proliferating Lymphoblasts, Accumulate in the Peripheral Blood of Immunosuppressed Patients , 1999, The Journal of experimental medicine.
[30] M. Epstein,et al. The Epstein-Barr Virus , 1979, Springer Berlin Heidelberg.
[31] T. Kurosaki,et al. Genetic analysis of B cell antigen receptor signaling. , 1999, Annual review of immunology.